Trial Profile
A single-dose study to evaluate the pharmacokinetics, safety, and tolerability of multiple formulations of omadacycline in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2020
Price :
$35
*
At a glance
- Drugs Omadacycline (Primary) ; Omadacycline (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Nosocomial infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- 24 Aug 2020 Results published in the Antimicrobial Agents and Chemotherapy
- 10 Oct 2016 Results published in the Antimicrobial Agents and Chemotherapy
- 02 May 2012 New trial record